FindTrial
Sign In

Human Papillomavirus 9-valent Vaccine, Recombinant

BIOLOGICAL6 trials

Sponsors

University of British Columbia, University Hospital Virgen de las Nieves, Louisiana State University Health Sciences Center in New Orleans, Western Institute for Veterans Research, Centre Oscar Lambret

Conditions

Anal Intraepithelial NeoplasiaAnogenital CancerAnogenital WartsCervical CancerCervical Intraepithelial NeoplasiaCervical LesionHIV InfectionsHPV Infection

Phase 2

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
RecruitingNCT05625633
Western Institute for Veterans ResearchWarts
Start: 2024-03-25End: 2026-12-31Target: 120Updated: 2024-04-05
Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions
RecruitingNCT06658405
Centre Oscar LambretCervical Lesion
Start: 2025-01-13End: 2031-12-31Target: 85Updated: 2026-03-18
Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure
Not yet recruitingNCT06681636
National Institute of Hygiene and Epidemiology, VietnamAnogenital Cancer, Anogenital Warts, Cervical Cancer +1
Start: 2024-12-14End: 2027-12-31Target: 300Updated: 2024-11-08

Phase 4

Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine
CompletedNCT02968420
University of British ColumbiaHuman Papillomavirus
Start: 2017-09-11End: 2019-05-15Updated: 2021-06-25
Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women
Active, not recruitingNCT04270773
University Hospital Virgen de las NievesHIV Infections, HPV Infection
Start: 2020-02-12End: 2024-12-30Target: 158Updated: 2024-07-10
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
RecruitingNCT05266898
Louisiana State University Health Sciences Center in New OrleansAnal Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia, Human Immunodeficiency Virus +4
Start: 2022-11-30End: 2026-06-30Target: 250Updated: 2025-04-18